A Schedule 13D filed on 6 November 2026 shows OPI VII, a Delaware limited partnership managed by OrbiMed Advisors LLC, holds 3,589,132 shares of Aspen Neuroscience, Inc., equal to approximately 12.3% of the company's outstanding shares.
The Schedule 13D filed on 4 November 2026 shows Main Street Capital Corp reporting a position in MSC Income Fund, Inc. and stating it has no present plans or proposals of the kind listed in Item 4 of the form.
A Schedule 13D filed on 4 November 2026 shows Saba Capital Management, L.P. disclosed a stake in Invesco Senior Income Trust bought for approximately $23,061,256 and said it may seek board seats, propose buy-backs or push for the fund's liquidation.
A filing with the Financial Conduct Authority shows investment vehicles connected with Hargreaves Services director Nicholas Mills sold 800,000 ordinary shares at 876.0p each on 2 November 2026.
The Schedule 13D filed by YA II PN, Ltd. on 30 October 2026 discloses an option agreement giving the fund the right to acquire half of Ultra AI Holdings LLC, the entity that holds 5,000,000 shares of Ives Ultra AI Opportunities Inc.
SEC filings show Westinghouse's shareholders, Brookfield Asset Management and Cameco, have disclosed a non-binding US–Korea framework that includes a Korean equity investment in the company.
What the registers and filings showed this week, the stories Loro found in them, and the numbers behind each one. Starts in the new year; register now to get it from the first issue.
We will email you to confirm your address, then send the Loro newsletter when it starts. We do not sell or share your data. Unsubscribe at any time. How we handle it.
